Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,232Revenue $M260Net Margin (%)25.8Z-Score34.9
Enterprise Value $M8,542EPS $0.9Operating Margin %37.6F-Score5
P/E(ttm))69.7Cash Flow Per Share $0.2Pre-tax Margin (%)37.7Higher ROA y-yY
Price/Book13.810-y EBITDA Growth Rate %0Quick Ratio7.8Cash flow > EarningsY
Price/Sales25.75-y EBITDA Growth Rate %0Current Ratio8.1Lower Leverage y-yY
Price/Cash Flow306y-y EBITDA Growth Rate %245ROA % (ttm)8.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)10.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M75.0ROI % (ttm)2.8Gross Margin Increase y-yN

Gurus Latest Trades with PCYC

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PCYCMariko Gordon 2014-03-31 Add0.02%$100.49 - $151.61
($129.71)
$ 124.75-4%Add 112.41%9,295
PCYCJoel Greenblatt 2014-03-31 Buy 0.01%$100.49 - $151.61
($129.71)
$ 124.75-4%New holding, 9591 sh.9,591
PCYCMariko Gordon 2013-12-31 Add0.01%$99.28 - $139.59
($121.32)
$ 124.753%Add 130.07%4,376
PCYCMariko Gordon 2013-09-30 Buy 0.01%$84.5 - $132.49
($110.93)
$ 124.7512%New holding, 1902 sh.1,902
PCYCJoel Greenblatt 2013-03-31 Sold Out -0.14%$57.78 - $94.2
($77.47)
$ 124.7561%Sold Out0
PCYCJoel Greenblatt 2012-12-31 Buy 0.14%$47.87 - $69.78
($58.72)
$ 124.75112%New holding, 41832 sh.41,832
PCYCGeorge Soros 2012-06-30 Sold Out -0.04%$25.72 - $53.44
($32.62)
$ 124.75282%Sold Out0
PCYCGeorge Soros 2012-03-31 Buy 0.04%$14.99 - $28.68
($20.91)
$ 124.75497%New holding, 100000 sh.100,000
PCYCPRIMECAP Management 2011-06-30 Add0.01%$5.66 - $10.63
($7.17)
$ 124.751640%Add 21.34%4,011,958
PCYCPRIMECAP Management 2010-06-30 Add0.01%$5.53 - $8.18
($6.98)
$ 124.751687%Add 43.36%3,306,481
PCYCPRIMECAP Management 2009-09-30 Add$1.2299 - $2.32
($1.49)
$ 124.758272%Add 51.48%2,300,678
PCYCPRIMECAP Management 2009-06-30 Reduce$1.02 - $1.39
($1.24)
$ 124.759960%Reduce -27.71%1,518,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PCYC is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PCYC Joel Greenblatt 2014-03-319,5910.010.01New Buy
PCYC Mariko Gordon 2014-03-319,2950.010.04+112.41%
PCYC PRIMECAP Management 2014-03-312,380,7393.170.27
Premium Most recent portfolio changes are included for Premium Members only!


PCYC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hemmi GregorySr. VP Chemical Operations 2014-03-05Sell15,000$140-12.11view
Sjovall Boultbee Paula SEVP, Sales and Marketing 2014-03-05Sell20,000$138.22-10.98view
McGreivy JesseChief Medical Officer 2014-03-05Sell6,563$139.66-11.9view
Fardis MariaChief of Oncology Ops & Allian 2014-03-05Sell3,000$140.5-12.43view
Chang Betty YVP, Research/Biology 2014-03-04Sell17,500$137.97-10.82view
HALVORSON ERIC HDirector 2014-03-04Sell3,472$138.33-11.05view
van den Broek RichardDirector 2014-02-27Sell78,835$146.63-16.09view
Tan HeowChief Quality&Tech Operations 2013-12-19Sell5,000$100.8721.98view
Hemmi GregoryVP Chemical Operations 2013-12-18Sell20,000$100.5222.4view
Zanganeh MakyCOO 2013-12-16Sell20,000$107.5514.4view

Press Releases about PCYC :

    Quarterly/Annual Reports about PCYC:

    News about PCYC:

    Articles On GuruFocus.com
    Weekly Insider Sells Highlight: BX, PCYC, MAS, ITMN Mar 03 2014 
    comment on PCYC Mar 06 2013 
    Weekly CEO Buys Highlight: PCYC, HLX, FSC, CREG, BTX Jun 25 2011 
    Pharmacyclics Inc. Reports Operating Results (10-Q) Feb 08 2011 
    Pharmacyclics Inc. Reports Operating Results (10-Q) Nov 09 2010 
    Weekly CEO Buys Highlight: Pharmacyclics Inc, Saul Centers Inc, Charming Shoppes Inc, ProLogis, Exce Jun 27 2010 
    Pharmacyclics Inc. Reports Operating Results (10-Q) May 07 2010 
    cooldecency99 note on PCYC May 01 2010 
    cooldecency99 note on PCYC May 01 2010 
    Pharmacyclics Inc. Reports Operating Results (10-Q) Nov 03 2009 

    More From Our Partners
    Pharmacyclics (PCYC) Jumps: Stock Rises 15% - Tale of the Tape Jul 30 2014 - ZACKS

    More From Other Websites
    Pharmacyclics (PCYC) Jumps: Stock Rises 15% Jul 30 2014
    Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of... Jul 28 2014
    Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of... Jul 28 2014
    Pharmacyclics/Johnson & Johnson Drug Backed for EU Approval Jul 28 2014
    U.S. FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications Jul 28 2014
    1:19 pm Pharmacyclics: FDA grants regular full approval for IMBRUVICA for two indications Jul 28 2014
    U.S. FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications Jul 28 2014
    European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval of IMBRUVICA®... Jul 25 2014
    European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval of IMBRUVICA®... Jul 25 2014
    Europe backs new leukaemia drugs from J&J and Gilead Jul 25 2014
    Can the Rally in Pharmacyclics (PCYC) Shares Continue? Jul 24 2014
    [video] Upside ahead for Vertex: Pro Jun 24 2014
    Pharmacyclics' Imbruvica Under FDA Priority Review Jun 10 2014
    Pharmacyclics Jun 09 2014
    Pharmacyclics reports sNDA for Imbruvica accepted, priority review granted Jun 09 2014
    Supplemental New Drug Application for IMBRUVICA® Accepted by the U.S. FDA and Priority Review... Jun 09 2014
    PCYC, ALXN And PFE, 3 Drugs Stocks Pushing The Industry Lower Jun 06 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide